Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study Academic Article uri icon

Overview

MeSH Major

  • Decision Support Techniques
  • Early Detection of Cancer
  • Kallikreins
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • For men in their fifties, screening should focus on those in the top 10% to 25% of PSA values because the majority of subsequent cases of distant metastasis are found among these men. Testing of four kallikrein markers in men with an elevated PSA could aid biopsy decision making.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4496315

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.01.009

PubMed ID

  • 25682340

Additional Document Info

start page

  • 207

end page

  • 13

volume

  • 68

number

  • 2